William Beaumont Hospital - Royal Oak Campus - Infectious Disease — Royal Oak, Michigan

William Beaumont Hospital - Royal Oak Campus - Infectious Disease is a clinical research site located in Royal Oak, Michigan, United States 48073-6700.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

William Beaumont Hospital - Royal Oak Campus - Infectious Disease has participated in 3 clinical trials.

Therapeutic areas: COVID-19, Bacterial Infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Royal Oak

Browse all research sites in Michigan · View every site in Royal Oak

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for William Beaumont Hospital - Royal Oak Campus - Infectious Disease?

William Beaumont Hospital - Royal Oak Campus - Infectious Disease has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has William Beaumont Hospital - Royal Oak Campus - Infectious Disease conducted?

William Beaumont Hospital - Royal Oak Campus - Infectious Disease has 3 clinical trials on record. Their work covers COVID-19, Bacterial Infection.

Is William Beaumont Hospital - Royal Oak Campus - Infectious Disease accredited by Crixeo Clinical Trials?

William Beaumont Hospital - Royal Oak Campus - Infectious Disease has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about William Beaumont Hospital - Royal Oak Campus - Infectious Disease?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.